DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Griffiths CE, Reich K, Lebwohl M. et al.
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Lancet (London, England) 2015;
386: 541-551
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.